
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT We have developed synthetic double-stranded oligodeoxynucleotides (ODN) as ‘decoy’ cis elements that block the binding of nuclear factors to promoter regions of targeted genes,
resulting in the inhibition of gene transactivation in vivo. In the present study, we employed decoy ODN targeting the transcription factor nuclear factor-kappaB (NF-kappaB) binding
cis-elements to hepatic metastasis of murine reticulosarcoma M5076 in mice. Intravenous inoculation of M5076 into mice caused a marked increase in gene expression of interleukin-1β, tumor
necrosis factor-α and intercellular adhesion molecule-1 in the liver, whereas intravenous treatment with NF-kappaB decoy ODN reduced M5076-induced transactivation of these genes. Treatment
with NF-kappaB decoy ODN, but not scrambled decoy ODN, significantly inhibited hepatic metastasis of M5076 in mice, and furthermore the combined treatment of NF-kappaB decoy ODN with an
anti-cancer drug resulted in complete inhibition of hepatic metastasis in half of the mice, without affecting myelosuppression induced by the anti-cancer drug. Here, NF-kappaB decoy ODN
inhibited hepatic metastasis of M5076 in mice possibly through a decrease in transactivation of important NF-kappaB-driven genes and also potentiated the anti-metastatic effect of an
anti-cancer drug, demonstrating the first successful in vivo therapy for cancer metastasis using NF-kappaB decoy ODN as a novel molecular decoy approach. Access through your institution Buy
or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 6 print issues and online
access $259.00 per year only $43.17 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which
are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS
TLR3 ACTIVATION ENHANCES ANTITUMOR EFFECTS OF SORAFENIB IN HEPATOCELLULAR CARCINOMA BY ACTIVATING NK CELL FUNCTIONS THROUGH ERK AND NF-ΚB PATHWAYS Article Open access 02 November 2024
NF-ΚB-ACTIVATED ONCOGENE INHIBITION STRATEGY FOR CANCER GENE THERAPY Article Open access 03 September 2024 RU(II)-BASED COMPLEXES CONTAINING 2-THIOURACIL DERIVATIVES SUPPRESS LIVER CANCER
STEM CELLS BY TARGETING NF-ΚB AND AKT/MTOR SIGNALING Article Open access 03 June 2024 REFERENCES * Fidler IJ . Critical factors in the biology of human cancer metastasis: Twenty-eighth
G.H.A. Clowes Memorial Award Lecture _Cancer Res_ 1990 50: 6130–6138 CAS Google Scholar * Talmadge JE . The selective nature of metastasis _Cancer Metast Rev_ 1983 2: 25–40 Article CAS
Google Scholar * Weiss L, Ward PM . Cell detachment and metastasis _Cancer Metast Rev_ 1983 2: 111–127 Article CAS Google Scholar * Liotta LA . Tumor invasion and metastasis. Role of the
extracellular matrix: Rhoads Memorial Award Lecture _Cancer Res_ 1986 46: 1–7 Article CAS Google Scholar * Nicolson GL . Cancer metastasis: organ colonization and the cell-surface
properties of malignant cells _Biochim Biophys Acta_ 1982 695: 113–176 CAS PubMed Google Scholar * Weiss L, Orr FW, Honn KV . Interactions of cancer cells with the microvasculature during
metastasis _FASEB J_ 1988 2: 12–21 Article CAS Google Scholar * Rice GE, Bevilacqua MP . An inducible endothelial cell surface glycoprotein mediates melanoma adhesion _Science_ 1989 246:
1303–1306 Article CAS Google Scholar * Albelda SM . Role of integrins and other cell adhesion molecules in tumor progression and metastasis _Lab Invest_ 1993 68: 4–17 CAS Google Scholar
* Okahara H, Yagita H, Miyake K, Okumura K . Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor α enhancement of
experimental metastasis _Cancer Res_ 1994 54: 3233–3236 CAS PubMed Google Scholar * Glinsky GV . Anti-adhesion cancer therapy _Cancer Metast Rev_ 1998 17: 177–185 Article CAS Google
Scholar * Bani MR, Garofalo A, Scanziani E, Giavazzi R . Effect of interleukin-1-beta on metastasis formation in different tumor systems _J Natl Cancer Inst_ 1991 83: 119–123 Article CAS
Google Scholar * Butcher EC . Warner-Lambert/Parke-Davis Award lecture. Cellular and molecular mechanisms that direct leukocyte traffic _Am J Pathol_ 1990 136: 3–11 CAS PubMed PubMed
Central Google Scholar * Cotran RS . American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity _Am J Pathol_ 1987 129:
407–413 CAS PubMed PubMed Central Google Scholar * Stoolman LM . Adhesion molecules controlling lymphocyte migration _Cell_ 1989 56: 907–910 Article CAS Google Scholar * Lenardo MJ,
Baltimore D . NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control _Cell_ 1989 58: 227–229 Article CAS Google Scholar * Neish AS _et al_. Functional analysis
of the human vascular cell adhesion molecule 1 promoter _J Exp Med_ 1992 176: 1583–1593 Article CAS Google Scholar * Brennan DC, Jevnika AM, Takei F, Reubin-Kelley VE . Mesangial cell
accessory functions: mediation by intercellular adhesion molecule-1 _Kidney Int_ 1990 38: 1039–1046 Article CAS Google Scholar * Bielinska A, Shivdasani RA, Zhang LQ, Nabel GJ .
Regulation of gene expression with double-stranded phosphorothioate oligonucleotides _Science_ 1990 250: 997–1000 Article CAS Google Scholar * Morishita R, Higaki J, Tomita N, Ogihara T .
Application of transcription factor ‘decoy’ strategy as means of gene therapy and study of gene expression in cardiovascular disease _Circ Res_ 1998 82: 1023–1028 Article CAS Google
Scholar * Yamada T _et al_. _In vivo_ identification of a negative regulatory element in the mouse renin gene using direct gene transfer _J Clin Invest_ 1995 96: 1230–1237 Article CAS
Google Scholar * Morishita R _et al_. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation _in vivo_ _Proc Natl Acad Sci
USA_ 1995 92: 5855–5859 Article CAS Google Scholar * Morishita R _et al_. _In vivo_ transfection of _cis_ element ‘decoy’ against nuclear factor-kB binding site prevents myocardial
infarction _Nature Med_ 1997 3: 894–899 Article CAS Google Scholar * Kawamura I _et al_. Intratumoral injection of oligonucleotides to the NFkB binding site inhibits cachexia in a mouse
tumor model _Gene Therapy_ 1999 6: 91–97 Article CAS Google Scholar * Talmadge JE, Key ME, Hart IR . Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin
_Cancer Res_ 1981 41: 1271–1280 CAS PubMed Google Scholar * Hart IR, Talmadge JE, Fidler IJ . Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth
_Cancer Res_ 1981 41: 1281–1287 CAS PubMed Google Scholar * Yamaoka M _et al_. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor
o-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470) _Cancer Res_ 1993 53: 4262–4267 CAS Google Scholar * Xie K _et al_. Direct correlation between expression of endogenous inducible
nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362 _Cancer Res_ 1995 55: 3123–3131 CAS
PubMed Google Scholar * Higgins KA _et al_. Antisense inhibition of the p65 subunit of NF-kB blocks tumorigenicity and causes tumor regression _Proc Natl Acad Sci USA_ 1993 90: 9901–9905
Article CAS Google Scholar * Bours V _et al_. The NF-kB transcription factor and cancer: high expression of NF-kB- and IkB-related proteins in tumor cell lines _Biochem Pharmacol_ 1994
47: 145–149 Article CAS Google Scholar * Tozawa K, Sakurada S, Kohri K, Okamoto T . Effects of anti-nuclear factor kB reagents in blocking adhesion of human cancer cells to vascular
endothelial cells _Cancer Res_ 1995 55: 4162–4167 CAS PubMed Google Scholar * La Porta CAM, Comolli R . PKC-dependent modulation of IkBα-NFkB pathway in low metastatic B16F1 murine
melanoma cells and in highly metastatic BL6 cells _Anticancer Res_ 1998 18: 2591–2597 CAS PubMed Google Scholar * Hinz M _et al_. NF-kB function in growth control: regulation of cyclin D1
expression and G0/G1-to-S-phase transition _Mol Cell Biol_ 1999 19: 2690–2698 Article CAS Google Scholar * Siebenlist U, Franzoso G, Brown K . Structure, regulation and function of NF-kB
_Annu Rev Cell Biol_ 1994 10: 405–455 Article CAS Google Scholar * Wulczyn FG, Krappmann D, Scheidereit C . The NF-kB/Rel and IkB gene families: mediators of immune response and
inflammation _J Mol Med_ 1996 74: 749–769 Article CAS Google Scholar * Kittelberger R, Davis PF, Stehbens WE . An improved immunofluorescence technique for the histological examination of
blood vessel tissue _Acta Histochem_ 1989 86: 137–142 Article CAS Google Scholar * Morishita R _et al_. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the
vessel wall _in vivo_: enhanced therapeutic utility for restenosis by HVJ-liposome delivery _Gene_ 1994 149: 13–19 Article CAS Google Scholar * Aoki M _et al_. _In vivo_ transfer
efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method _Biochem Biophys Res Commun_ 1997 231: 540–545 Article CAS Google Scholar * Kaneda Y, Iwai K, Uchida
T . Increased expression of DNA cointroduced with nuclear protein in adult rat liver _Science_ 1989 243: 375–378 Article CAS Google Scholar * Suzuki J _et al_. Prevention of graft
coronary arteriosclerosis by antisense cdk 2 kinase oligonucleotide _Nature Med_ 1997 3: 900–903 Article CAS Google Scholar Download references AUTHOR INFORMATION Author notes * I
Kawamura and S Tsujimoto: The first two authors contributed equally to this work AUTHORS AND AFFILIATIONS * Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka,
Japan I Kawamura, S Tsujimoto, T Manda, M Tomoi & T Goto * Department of Geriatric Medicine, Osaka University Medical School, Japan R Morishita, N Tomita & T Ogihara * Division of
Gene Therapy Science, Osaka University Medical School, Japan R Morishita & Y Kaneda Authors * I Kawamura View author publications You can also search for this author inPubMed Google
Scholar * R Morishita View author publications You can also search for this author inPubMed Google Scholar * S Tsujimoto View author publications You can also search for this author inPubMed
Google Scholar * T Manda View author publications You can also search for this author inPubMed Google Scholar * M Tomoi View author publications You can also search for this author inPubMed
Google Scholar * N Tomita View author publications You can also search for this author inPubMed Google Scholar * T Goto View author publications You can also search for this author inPubMed
Google Scholar * T Ogihara View author publications You can also search for this author inPubMed Google Scholar * Y Kaneda View author publications You can also search for this author
inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Kawamura, I., Morishita, R., Tsujimoto, S. _et al._ Intravenous injection of
oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. _Gene Ther_ 8, 905–912 (2001). https://doi.org/10.1038/sj.gt.3301478
Download citation * Received: 17 August 2000 * Accepted: 06 April 2001 * Published: 27 June 2001 * Issue Date: 01 June 2001 * DOI: https://doi.org/10.1038/sj.gt.3301478 SHARE THIS ARTICLE
Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided
by the Springer Nature SharedIt content-sharing initiative KEYWORDS * gene therapy * decoy * HVJ-liposome method * M5076 * hepatic metastasis